Clinical Trial Update: A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection [Phase 3]

View source ↗

Summary

Phase III trial evaluating the safety and efficacy of entecavir in pediatric patients with chronic hepatitis B; completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis Infection in Pediatric Patients

Drugs mentioned

• ENTECAVIR (ENTECAVIR)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B Virus, Pediatric | Phase 3 | Status: COMPLETED | Results posted: 2014-04-21